Cargando…

Radioimmunotherapy in colorectal cancer treatment: present and future

Colorectal cancer (CRC) is a deadly form of cancer worldwide. Patients with locally advanced rectal cancer and metastatic CRC have a poor long-term prognosis, and rational and effective treatment remains a major challenge. Common treatments include multi-modal combinations of surgery, radiotherapy,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Jingyi, Sun, Zhuang, Gao, Zhaoya, Huang, Dandan, Hong, Haopeng, Gu, Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206275/ https://www.ncbi.nlm.nih.gov/pubmed/37234164 http://dx.doi.org/10.3389/fimmu.2023.1105180

Ejemplares similares

Gut microbiota: A novel and potential target for radioimmunotherapy in colorectal cancer
por: Yuan, Hanghang, et al.
Publicado: (2023)

Identification of a prognostic signature and ENTR1 as a prognostic biomarker for colorectal mucinous adenocarcinoma
por: Huang, An, et al.
Publicado: (2023)

Radioimmunotherapy study of (131)I-labeled Atezolizumab in preclinical models of colorectal cancer
por: Zhang, Linhan, et al.
Publicado: (2022)

Radioimmunotherapy: future prospects from the perspective of brachytherapy
por: Fleischmann, Maximilian, et al.
Publicado: (2021)

Metagenomic and targeted metabolomic analyses reveal distinct phenotypes of the gut microbiota in patients with colorectal cancer and type 2 diabetes mellitus
por: Yang, Yong, et al.
Publicado: (2023)

Surgical treatment of locally recurrent rectal cancer: a narrative review
por: Gao, Zhaoya, et al.
Publicado: (2021)

Pretargeted radioimmunotherapy in the treatment of metastatic medullary thyroid cancer
por: Kraeber–Bodéré, F., et al.
Publicado: (2009)

Radioimmunotherapy for solid tumors: spotlight on Glypican-1 as a radioimmunotherapy target
por: Sabanathan, Dhanusha, et al.
Publicado: (2021)

Predictive biomarkers of colon cancer immunotherapy: Present and future
por: Hou, Wanting, et al.
Publicado: (2022)

Colorectal cancer vaccines: The current scenario and future prospects
por: Jia, Wenqing, et al.
Publicado: (2022)

Immunostimulatory effects of radioimmunotherapy
por: Constanzo, Julie, et al.
Publicado: (2022)

Past, Present and Future: The Relationship Between Circular RNA and Immunity
por: Gu, Junjie, et al.
Publicado: (2022)

Radioimmunotherapy of Non-Hodgkin’s Lymphoma: From the ‘Magic Bullets’ to ‘Radioactive Magic Bullets’
por: Chamarthy, Murthy R., et al.
Publicado: (2011)

Radioimmunotherapy Improves Survival of Rats with Microscopic Liver Metastases of Colorectal Origin
por: de Jong, Gabie M., et al.
Publicado: (2009)

Combination Radioimmunotherapy Strategies for Solid Tumors
por: Zaheer, Javeria, et al.
Publicado: (2019)

Pretargeted Molecular Imaging and Radioimmunotherapy
por: Goldenberg, David M., et al.
Publicado: (2012)

Radioimmunotherapy: a brief overview
por: Ng, DCE
Publicado: (2006)

Is radioimmunotherapy a 'magic bullet'?
por: Kim, Sung-Hyun
Publicado: (2012)

Improvement of Radioimmunotherapy Using Pretargeting
por: Frampas, Eric, et al.
Publicado: (2013)

Trial Watch: Anticancer radioimmunotherapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Antigen-Specific Treatment Modalities in MS: The Past, the Present, and the Future
por: Derdelinckx, Judith, et al.
Publicado: (2021)

CD46 targeted (212)Pb alpha particle radioimmunotherapy for prostate cancer treatment
por: Li, Jun, et al.
Publicado: (2023)

Combination Radioimmunotherapy Approaches and Quantification of Immuno-PET
por: Kim, Jin Su
Publicado: (2016)

Famitinib enhances the antitumor effect of radioimmunotherapy in murine lung cancer
por: Yuan, Meng, et al.
Publicado: (2022)

Current progress and future perspectives of neoadjuvant anti-PD-1/PD-L1 therapy for colorectal cancer
por: Yang, Zhengyang, et al.
Publicado: (2022)

Repeated Intraperitoneal α-Radioimmunotherapy of Ovarian Cancer in Mice
por: Elgqvist, Jörgen, et al.
Publicado: (2010)

Advances in immunotyping of colorectal cancer
por: Wu, Yinhang, et al.
Publicado: (2023)

Radioimmunotherapy: A Specific Treatment Protocol for Cancer by Cytotoxic Radioisotopes Conjugated to Antibodies
por: Kawashima, Hidekazu
Publicado: (2014)

Gene-Edited Interleukin CAR-T Cells Therapy in the Treatment of Malignancies: Present and Future
por: Zhang, Zhengchao, et al.
Publicado: (2021)

Theragnostic Aspects and Radioimmunotherapy in Pediatric Tumors
por: Cimini, Andrea, et al.
Publicado: (2020)

Editorial: Radioimmunotherapy—Translational Opportunities and Challenges
por: Gaipl, Udo S., et al.
Publicado: (2020)

Dynamics of an Antitumour Model with Pulsed Radioimmunotherapy
por: Wang, Gang, et al.
Publicado: (2022)

Editorial: The Present and Future of Immunology Education
por: Bottaro, Andrea, et al.
Publicado: (2021)

Applications of Magnetite Nanoparticles in Cancer Immunotherapies: Present Hallmarks and Future Perspectives
por: Song, Qingle, et al.
Publicado: (2021)

Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future
por: Saura-Esteller, José, et al.
Publicado: (2022)

Radioimmunotherapy consolidation and rituximab maintenance in the initial treatment of follicular lymphoma
por: Buchegger, Franz, et al.
Publicado: (2011)

Perioperative immune checkpoint inhibition for colorectal cancer: recent advances and future directions
por: Chen, Jiao-Ting, et al.
Publicado: (2023)

The Role of PAM4 in the Management of Pancreatic Cancer: Diagnosis, Radioimmunodetection, and Radioimmunotherapy
por: Han, Suxia, et al.
Publicado: (2014)

An enrichment model using regular health examination data for early detection of colorectal cancer
por: Shi, Qiang, et al.
Publicado: (2019)

Editorial: Cellular Therapies: Past, Present and Future
por: Dressel, Ralf, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sh6h2up4ad6kpcaa0s2qqo4i5d